WHO ICTRP trial
Sugammadex provide better surgical condition and faster reversal of…
KCT0001090 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0001090 |
|---|---|
| Public title | Sugammadex provide better surgical condition and faster reversal of rocuronium-induced neuromuscular blockade compared with neostigmine on the patients undergoing laparoscopic surgery. |
| Scientific title | Sugammadex provide better surgical condition and faster reversal of rocuronium-induced neuromuscular blockade compared with neostigmine on the patients undergoing laparoscopic surgery. |
| Primary sponsor | Seoul National University Bundang Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Diseases of the digestive system |
| Interventions | Drug : We randomly assigned double blinded two groups, group N(TOF count 1-2) and group S(PTC count 1-2). Moderate block group gives reverse drug commonly used dose while deep block group gives sugammadex at recovery of general anesthesia. |
| Registration date | Apr 28, 2014 |
| Target size | 70 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: